TrialJCO precision oncology2024
Phase II Study of Defactinib (VS6063) in Patients With Tumors With
Marjorie G Zauderer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
TrialJCO precision oncology2024
Marjorie G Zauderer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.